ABCpred: a webserver for the discovery of acetyl-and butyryl-cholinesterase inhibitors
AA Malik, SC Ojha, N Schaduangrat… - Molecular Diversity, 2022 - Springer
Alzheimer's disease (AD) is one of the most common forms of dementia and is associated
with a decline in cognitive function and language ability. The deficiency of the cholinergic …
with a decline in cognitive function and language ability. The deficiency of the cholinergic …
In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug …
In the last years, in order to achieve a better treatment of Alzheimer's disease (AD), much
focus has been put on the development of cholinesterase (Acetylcholinesterase and …
focus has been put on the development of cholinesterase (Acetylcholinesterase and …
Computer-aided molecular design of 2-anilino 4-amino substituted quinazolines derivatives as malarial inhibitors
Quantitative structure–activity relationship studies conducted on forty-five (45) derivatives of
2-anilino 4-amino substituted quinazolines as malaria inhibitors to determine the structures …
2-anilino 4-amino substituted quinazolines as malaria inhibitors to determine the structures …
Fragment-based Drug Design of Antitumoral Molecules Polo-like Kinase 1 Inhibitors: In-silico Approach
A Attoui, W Sobhi, NEH Hammoudi… - Letters in Drug …, 2021 - ingentaconnect.com
Background: Kinase enzymes are reported to be very implicated in cancer. Polo-like kinase
1 (PLK1) is a protein kinase with a marked role in tumorigenesis and its inhibition is a …
1 (PLK1) is a protein kinase with a marked role in tumorigenesis and its inhibition is a …
Ligand-Based Drug Discovery on SARSCOV2 Target Protein
Severe Acute Respiratory Syndrome Coronavirus2 (SARSCOV2) is the virus that causes a
respiratory disease called coronavirus (COVID-19). The symptoms of SARSCOV2 are …
respiratory disease called coronavirus (COVID-19). The symptoms of SARSCOV2 are …